Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1500 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
Yposkesi–Andrew Lloyd Associates: public relations, 201807 service existent by ALA 2018-07-09
Dynacure–Andera Partners: investment, 201807 financing round totalling €47m incl lead investor Andera Partners 2018-07-06
Dynacure–France (govt): investment, 201807 financing round totalling €47m incl co-investor Bpifrance 2018-07-06
Dynacure–Idinvest Partners: investment, 201807 financing round totalling €47m incl co-investor Idinvest Partners 2018-07-06
Dynacure–Kurma: investment, 201807 financing round totalling €47m incl co-investor Kurma Partners 2018-07-06
Dynacure–Pontifax: investment, 201807 financing round totalling €47m incl co-investor Pontifax 2018-07-06
Dynacure–SEVERAL: investment, 201807 financing round €47m led by Andera Partners + incl Pontifax + Bpifrance + Kurma + IdInvest 2018-07-06
Netbiotix–Auriga: investment, 201807 financing round Series A totalling €7.5m incl lead investor Auriga Partners 2018-07-05
Netbiotix–Biocodex: investment, 201807 financing round Series A totalling €7.5m incl co-investor Biocodex 2018-07-05
Netbiotix–SEVERAL: investment, 201807 financing round Series A €7.5m led by Auriga Partners + incl Biocodex 2018-07-05
Laboratoire de Bromatologie de l’Ouest–Eurofins: investment, 201807 acquisition of LBO by Eurofins 2018-07-03
Pharma Omnium–NuPharm: investment, 201807 acquisition €na of Laboratoire Biodim from Pharma Omnium 2018-07-03
Mérieux–Deinove: antibiotics, 201806– collab antibotics drug discovery of bioMérieux + Deinove + AGIR project 2018-06-28
NodThera–5AM Ventures: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Epidarex Capital: investment, 201806 financing round Series A totalling £28m ($40m) incl existing co-investor Epidarex Capital 2018-06-25
NodThera–F-Prime: investment, 201806 financing round Series A totalling £28m ($40m) incl co-investor F-Prime Capital Partners 2018-06-25
NodThera–Selvita: investment, 201806 existing investor 2018-06-25
NodThera–SEVERAL: investment, 201806 financing round Series A £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Sofinnova: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
Erytech–JMP Securities: investor conference, 201806 supply service Erytech presents at JMP Securities 2018 Life Sciences Conference NY 2018-06-20
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics 2018-06-16
Onxeo–Nice & Green: investment, 201806–201903 equity line financing up to €5.4m with up to 4.7new shares 2018-06-15
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec 2018-06-15
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share 2018-06-14
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Enyo Pharma–Andera Partners: investment, 201806 financing round Series B totalling €40m incl new + co-investor Andera Partners 2018-06-04
Enyo Pharma–France (govt): investment, 201806 financing round Series B totalling €40m incl Bpifrance Large Venture + InnoBio + ITI 2018-06-04
Enyo Pharma–Morningside: investment, 201806 financing round Series B totalling €40m incl existing investor Morningside Venture Investments 2018-06-04
Enyo Pharma–Orbimed Advisors: investment, 201806 financing round Series B totalling €40m incl new + lead investor OrbiMed Private Investment VII 2018-06-04
Enyo Pharma–SEVERAL: investment, 201806 financing round Series B €40m led by new investor OrbiMed + incl Andera Partners + Bpifrance et al 2018-06-04
Enyo Pharma–Sofinnova: investment, 201806 financing round Series B totalling €40m incl existing investor Sofinnova Private Capital VII 2018-06-04
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Voluntis–SEVERAL: investment, 201805 IPO €30.1m at Euronext Paris with 2.15m new shares at €14/share 2018-05-30
Sanofi–Adaptive Biotechnologies: pharmacogenomics, 2010805– collab €na use of NGS-based clonoSEQ Assay in multiple myeloma trials of isatuximab 2018-05-29
Pierre Fabre–Roche: companion diagnostics, 201805– collab extension for developm of IHC CDx assay for ADC W0101 2018-05-18
Cellectis–SEVERAL: investment, 201805 public offering of Calyxt Inc $60.9m 4.6m+457k shares common stockat $15/share 2018-05-15
Pierre Fabre–BioSerenity: medical device, 201805– collab €na develop + marketing connected device for managing urinary incontinence 2018-05-14
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Harvard Univ–Cellectis: gene editing technology, 201805– collab Wyss Institute to use TALEN to recode a human genome 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
LabCorp–Eurofins: investment, 201804– acquisition $670m cash/debt free of Covance Food Solutions from LabCorp by Eurofins 2018-04-30
EryDel–SEVERAL: investment, 201804 financing round €26.5m led by Sofinnova Partners + incl Genextra + Innogest SGR 2018-04-24
EryDel–Sofinnova: investment, 201804 financing round totalling €26.5m inc lead investor Sofinnova Partners 2018-04-24
Onxeo–LifeSci: public relations, 201804 service existent IR US by LifeSci Advisors 2018-04-24
Onxeo–NewCap: public relations, 201804 service existent IR + strategic communication by NewCap 2018-04-24
LimFlow–SEVERAL: investment, 201804 financing round Series C €27m led by Sofinnova Crossover I Fund 2018-04-16
Shire–Servier: investment, 201804– acquisition of Shire’s oncology business for $2.4b in cash by Servier ANNOUNCED 2018-04-16
Biovertis–Deinove: investment, 201804–201805 acquisition of Biovertis/Morphochem for €900k in 500k new shares + 8m warrants 2018-04-13
Protec–Eurofins: investment, 201804 acquisition of Protec’s water + food testing business in France by Eurofins 2018-04-12
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Curetis–HC Wainwright: investor conference, 201804 supply service Curetis presents at HC Wainwright Global Life Sciences Conference in Monte Carlo 2018-04-08
Astute Medical–Mérieux: investment, 201804 acquisition $90m in cash by bioMérieux 2018-04-04
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
Eichrom Laboratoires–Eurofins: investment, 201804 acquisition by Eurofins 2018-04-04
LCF Rothschild–Andera Partners: investment, 201804 management buy-out of EdRIP by employees + renaming to Andera Partners 2018-04-04
Sofinnova–SEVERAL: investment, 201804 1st closing €275m of Sofinnova Crossover I fund 2018-04-04
Allogene Therapeutics–Cellectis: T-cell immunotherapy, 201804– collab continuation of Pfizer-Cellectis collaboration signed 201406 by Allogene 2018-04-03
Cellectis–SEVERAL: investment, 201804 public offering $175m ($163.7m net) with 5.646m ADSs at $31/ADS 2018-04-03
Young In Group–Eurofins: investment, 201804 acquisition of Lab Frontier Co Ltd from YIG by Eurofins 2018-04-03
Deinove–Redx Pharma: antibiotics, 201803– option + license agreem for Redx’ Novel Bacterial Topoisomerase Inhibitor programme 2018-03-22
DBV Technologies–SEVERAL: investment, 201803 global offering $172.5m public offering ADSs at $21.26 + private placement ordinary shares at €34.71 2018-03-20
Mérieux–Sartorius: bioreactors, 201803 supply of single-use viral vector manufacturing package to ABL Europe in Strasboug by SSB 2018-03-16
Valbiotis–Actifin: public relations, 201803 service financial communication existent by Actifin 2018-03-15
Valbiotis–Alize RP: public relations, 201803 service existent PR by Alize RP 2018-03-15
DBV Technologies–Barclays: investor conference, 201803 supply service DBV Technologies presents at Barclays Global Healthcare Conference 2018-03-14
Deinove–Naicons: antibiotics drug discovery, 201803– collab incl access to strain bank of Naicons 2018-03-08
Ventech–SEVERAL: investment, 201803 first closing €140m of Ventech Capital V fund with €200m target size 2018-03-07
NMDL-LCPL (NL)–Eurofins: investment, 201802 acquisition of NMDL-LCPL by Eurofins 2018-02-26
ASIT Biotech–SEVERAL: investment, 201802 private placement capital increase 2nd tranche €2.1m w 544k new shares at €3.83/share 2018-02-23
ASIT Biotech–SEVERAL: investment, 201802 warrant excercise €2.4m for 626k new shares at €3.83/share 2018-02-23
City Analysts–Eurofins: investment, 201802 acquisition of City Analysts Ltd by Eurofins 2018-02-23
Hybrigenics–Helixio: investment, 201802 management buy-out €na of Helixio from Hybrigenics 2018-02-19
BrainEver–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created BrainEver 2018-02-14
Brainiac–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Brainiac 2018-02-14
Chronocam–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Chronocam 2018-02-14
Chronolife–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Chronolife 2018-02-14
iBionext–SEVERAL: investment, 201802 2nd + final closing of iBionext Growth Fund with additional €44m bringing total to €90m 2018-02-14
Tilak Healthcare–iBionext: investment, 201802 existent investment by iBionext Growth Fund that co-created Tilak 2018-02-14
Swiss Medical Imaging Investment–RAD-x: investment, 201802 acquisition of SMII by RAD-x 2018-02-13
BioMeca–Synthelis: proteomic services, 201802– collab joint services for production + folding validation of difficult-to-express proteins 2018-02-12
Nosopharm–Andrew Lloyd Associates: public relations, 201802 service existent by ALA 2018-02-12
Nosopharm–France (govt): credit, 201802– interest-free loan €1m for preclinical developm of NOSO-502 from Bpifrance 2018-02-12
LCF Rothschild–SEVERAL: investment, 201802 closing €345m of BioDiscovery 5 fund of EdRIP 2018-02-07
Servier–ImmunoQure: therapeutic antibodies, 201802– collab developm of INF-alpha human autoantibody for autoimmune diseases 2018-02-06
Labo Van Poucke–Eurofins: investment, 201802 acquisition of LVP by Eurofins 2018-02-05
Foundry Innovation & Research 1–SEVERAL: investment, 201801 financing round Series C €40m of FIRE1 led by new investor Gilde Healthcare 2018-01-30
Helsinn–Scientific Centre of Monaco: cancer drug, 201801– collab research new pharmacological inhibitors for clear cell renal cell carcinoma 2018-01-30
Ablynx–Sanofi: investment, 201801–201806 acquisition recommended cash tender offer €3.9b with €45/share 2018-01-29
ASIT Biotech–SEVERAL: investment, 201801 private placement capital increase first tranche €9.4m w 2.46m new shares at €3.83/share 2018-01-25
Selcia–Eurofins: investment, 201801 acquisition of Selcia Ltd by Eurofins 2018-01-25
ImmuPharma–SEVERAL: investment, 201801 placing £10m of 6.945m new ordinary shares at 144p/share 2018-01-24
Craft Technologies–Eurofins: investment, 201802 acquisition of Craft Technologies Inc by Eurofins 2018-01-23
Bioverativ–Sanofi: investment, 201801–201803 acquisition cash tender offer $11.6b with $105/share 2018-01-22
Food Analytica (HU)–Eurofins: investment, 201801 acquisition by Eurofins 2018-01-18
Cellnovo–Flextronics: contract manufacturing, 201801 supply existent production of Cellnovo Diabetes Monitoring System + Cartridges by Flex 2018-01-17
HalioDx–SEVERAL: investment, 201801 financing round Series B €18.5m from new investors Bpifrance + Quest for Growth + Amundi + returning investors 2018-01-17
Novolyze–SEVERAL: grant, 201801 total of €1m public research programs + grants incl from French govt Investissement d’Avenir fund (LF) 2018-01-17
Novolyze–SEVERAL: investment, 201801 financing round €1.2m from private investors + family offices + business angels 2018-01-17
Sartorius–Synpromics: genomic technology, 201801 collab existent with Sartorius Stedim Cellca 2018-01-17
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Bionordic Nordic Life Science Days 2018 Stockholm 600x60px

» top